Adverse effects of antiepileptic drugs in north Indian pediatric outpatients

Clinical Neuropharmacology

Volumn 36, Issue 4, 2013, Pages 107-113

  Bansal, Dipika ^a   Azad, Chandrika ^b   Kaur, Manpreet ^a   Rudroju, Neelima ^a   Vepa, Pravallika ^a   Guglani, Vishal ^b  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

^b GOVERNMENT MEDICAL COLLEGE AND HOSPITAL   (India)

Author keywords

Adverse drug reactions; Antiepileptic drugs; Epilepsy; Pediatrics

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLOBAZAM; CLONAZEPAM; DIAZEPAM; ETIRACETAM; LAMOTRIGINE; PHENOBARBITAL; PHENYTOIN; VALPROIC ACID;

ADOLESCENT; ADULT; ANTICONVULSANT THERAPY; ARTICLE; ATAXIA; ATONIC SEIZURE; BEHAVIOR DISORDER; BENIGN CHILDHOOD EPILEPSY; CHILD; CLINICAL FEATURE; COMPLEX PARTIAL SEIZURE; CONSTIPATION; CONTROLLED STUDY; DECREASED APPETITE; DEMOGRAPHY; DISEASE SEVERITY; DIZZINESS; DROWSINESS; DRUG ERUPTION; DRUG INDUCED HEADACHE; EEG ABNORMALITY; ENURESIS; FATIGUE; FEMALE; GASTRITIS; GENERALIZED EPILEPSY; HAIR LOSS; HUMAN; HYPOTHYROIDISM; INCONTINENCE; INFANT; LETHARGY; MAJOR CLINICAL STUDY; MALE; MEGALOBLASTIC ANEMIA; MEMORY DISORDER; MONOTHERAPY; MYOCLONUS EPILEPSY; MYOCLONUS SEIZURE; NEUTROPENIA; NYSTAGMUS; OBSERVATIONAL STUDY; OUTPATIENT CARE; PATIENT MONITORING; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; RICKETS; SCHOOL CHILD; SIMPLE PARTIAL SEIZURE; STRUCTURED QUESTIONNAIRE; SYMPTOMATIC EPILEPSY; TONIC CLONIC SEIZURE; TONIC SEIZURE; TREMOR; VISUAL DISORDER; VOMITING;

EID: 84880811378     PISSN: 03625664     EISSN: 1537162X     Source Type: Journal    
DOI: 10.1097/WNF.0b013e31829a498d     Document Type: Article

References (20)

1. Russ SA, Larson K, Halfon N. A national profile of childhood epilepsy and seizure disorder. Pediatrics 2012;129: 256-264.
2. Berg AT, Scheffer IE. New concepts in classification of the epilepsies: entering the 21st century. Epilepsia 2011;52: 1058-1062.
3. World Health Organization. Epilepsy. Available at: http: //www.who.int/ mediacentre/factsheets/fs999/en/index.html. Accessed August 21, 2012.
4. Guerrini R. Epilepsy in children. Lancet 2006;367: 499-524.
5. Banerjee TK, Ray BK, Das SK, et al. A longitudinal study of epilepsy in Kolkata, India. Epilepsia 2010;51: 2384-2391.
6. Goel D, Agarwal A, Dhanai JS, et al. Comprehensive rural epilepsy surveillance programme in Uttarakhand state of India. Neurol India 2009;57: 355-356.
7. Radhakrishnan K, Pandian JD, Santhoshkumar T, et al. Prevalence, knowledge, attitude, and practice of epilepsy in Kerala, South India. Epilepsia 2000;41: 1027-1035.
8. Herranz JL, Armijo JA, Arteaga R. Clinical side effects of phenobarbital, primidone, phenytoin, carbamazepine, and valproate during monotherapy in children. Epilepsia 1988;29: 794-804.
9. Namazi S, Borhani-Haghighi A, Karimzadeh I. Adverse reactions to antiepileptic drugs in epileptic outpatients: a cross-sectional study in Iran. Clin Neuropharmacol 2011;34: 79-83.
10. Roopa BS, Narayan SS, Sharma GR, et al. Pattern of adverse drug reactions to anti-epileptic drugs: a cross-sectional one-year survey at a tertiary care hospital. Pharmacoepidemiol Drug Saf 2008;17: 807-812.
11. Zeng K, Wang X, Xi Z, et al. Adverse effects of carbamazepine, phenytoin, valproate and lamotrigine monotherapy in epileptic adult Chinese patients. Clin Neurol Neurosurg 2010;112: 291-295.
12. The Uppsala Monitoring centre. The use of the WHO-UMC System for standardized case causality assessment. Available at: http: //www.who-umc.org/ Graphics/24734.pdf. Accessed August 10, 2012.
13. Lau PM, Stewart K, Dooley MJ. Comment: hospital admissions resulting from preventable adverse drug reactions. Ann Pharmacother 2003;37: 303-304.
14. Hartwig SC, Siegel J, Schneider PJ. Preventability and severity assessment in reporting adverse drug reactions. Am J Hosp Pharm 1992;49: 2229-2232.
15. Baker GA, Jacoby A, Buck D, et al. Quality of life of people with epilepsy: a European study. Epilepsia 1997;38: 353-362.
16. Canevini MP, De Sarro G, Galimberti CA, et al. Relationship between adverse effects of antiepileptic drugs, number of coprescribed drugs, and drug load in a large cohort of consecutive patients with drug-refractory epilepsy. Epilepsia 2010;51: 797-804.
17. Carpay JA, Aldenkamp AP, van Donselaar CA Complaints associated with the use of antiepileptic drugs: results from a community-based study. Seizure 2005;14: 198-206.
18. Hilton EJ, Hosking SL, Betts T. The effect of antiepileptic drugs on visual performance. Seizure 2004;13: 113-128.
19. Ramesh M, Pandit J, Parthasarathi G. Adverse drug reactions in a south Indian hospital-their severity and cost involved. Pharmacoepidemiol Drug Saf 2003;12: 687-692.
20. Central Drugs Standard Control Organization. Pharmacovigilance Programme of India (PvPI) for assuring drug safety. Available at: http: // www.cdsco.nic.in/pharmacovigilance.htm. Accessed August 15, 2012.